Search

Search results

124 results found

Michelle Pebole, PhD

Michelle joined the TRACTS team as a postdoctoral fellow in August 2022, after earning her MA in Exercise and Sport Science from the University of North Carolina at Chapel Hill and PhD in Kinesiology and Community Health from the University of Illinois at Urbana-Champaign. She is interested in...

Mikayla Day, B.A.

Mikayla received her Bachelor's degree in Psychology with a concentration in Neuroscience from the Pennsylvania State University. During her time as an undergraduate, she worked in Dr. Jenae Neiderhiser's Gene X Environment Interplay Throughout the Lifespan Lab where she collected and managed data...

BCH Develops 3-D Printed Device for Strabismus Surgery Training

Faculty from Boston Children's Hospital, including Gena Heidary, MD, PhD, Eric Gaier, MD, PhD, and David Hunter, MD, PhD, are working with their clinical trainees and the hospital's Applied Engineering team to develop a 3-D printed surgical eye simulator. Know as the "Strabismus Trainer," the device...

Aging TRACTS (ATRACTS)

Aging TRACTS (ATRACTS) is a new study that seeks to learn about brain and behavioral changes in middle aged and older Veterans. We hope to better understand the impact combat exposure has on brain function and risk of Alzheimer’s Disease in individuals who have been deployed. We will examine whether...

Virtual TRACTS (V-TRACTS)

Virtual TRACTS Moves the ten hour testing day at the VA Hospital into three online sessions from the comfort of your home. One, you will meet with a research assistant and complete a series of questionnaires to provide our psychologists with important background information about your military...

Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer's-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia

Shi, Haoshen, Zhuoran Yin, Yosef Koronyo, Dieu-Trang Fuchs, Julia Sheyn, Miyah Davis, Jered Wilson, et al. 2022. “Regulating Microglial MiR-155 Transcriptional Phenotype Alleviates Alzheimer’s-Induced Retinal Vasculopathy by Limiting Clec7a/Galectin-3+ Neurodegenerative Microglia”. Acta Neuropathol Commun 10 (1): 136.